Cargando…

A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India

The aim of the present study was to observe adverse drug reactions (ADRs) with respect to polypharmacy at tertiary care centre at Bastar, Jagdalpur (Government Medical College, Jagdalpur). A prospective, observational evaluation of the ADRs conducted over a period of 6 months in Department of Medici...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, H, Dulhani, N, Kumar, BN, Singh, P, Tewari, P, Nayak, K
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035895/
https://www.ncbi.nlm.nih.gov/pubmed/21331200
http://dx.doi.org/10.4103/0975-1483.62222
_version_ 1782197824337739776
author Singh, H
Dulhani, N
Kumar, BN
Singh, P
Tewari, P
Nayak, K
author_facet Singh, H
Dulhani, N
Kumar, BN
Singh, P
Tewari, P
Nayak, K
author_sort Singh, H
collection PubMed
description The aim of the present study was to observe adverse drug reactions (ADRs) with respect to polypharmacy at tertiary care centre at Bastar, Jagdalpur (Government Medical College, Jagdalpur). A prospective, observational evaluation of the ADRs conducted over a period of 6 months in Department of Medicine in Government Medical College, Jagdalpur. During the study period, a total of about 4850 patients visited the OPD and inpatient ward of medicine department, and 154 ADRs events were reported. Out of 154 reports that were identified, a higher percentage of ADRs in females (51.29%) was observed as compared to males (48.7%). Of the 154 ADRs, 76 (49.35%) were found to be mild, 55 moderate (35.71%), and 23 severe (14.93%). A total of 99 (64.28%) ADRs were observed in patients receiving four or more medications concurrently. Conversely 55 (35.71%) ADRs were detected in patients using three or less medicines. The largest number of reports was associated with antimicrobial therapy (28.57%), followed by antihypertensive (24.02%) and antidiabetics (14.28%). Among the affected organ systems, gastrointestinal ADRs constituted a major component (39.61%) followed by skin reactions (28.57%). On causality assessment, nearly 36.36% ADRs were considered as probable, 31.16% possible, and 9.74% could not be categorized and were placed under unassessable. Expected, limited ADR are permissible in normal clinical setting, but the present study focuses on the result showing increased and amplified ADR associated with the polypharmacy practices, which may be curtailed with rational drug prescribing habit.
format Text
id pubmed-3035895
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30358952011-02-17 A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India Singh, H Dulhani, N Kumar, BN Singh, P Tewari, P Nayak, K J Young Pharm General Pharmacy The aim of the present study was to observe adverse drug reactions (ADRs) with respect to polypharmacy at tertiary care centre at Bastar, Jagdalpur (Government Medical College, Jagdalpur). A prospective, observational evaluation of the ADRs conducted over a period of 6 months in Department of Medicine in Government Medical College, Jagdalpur. During the study period, a total of about 4850 patients visited the OPD and inpatient ward of medicine department, and 154 ADRs events were reported. Out of 154 reports that were identified, a higher percentage of ADRs in females (51.29%) was observed as compared to males (48.7%). Of the 154 ADRs, 76 (49.35%) were found to be mild, 55 moderate (35.71%), and 23 severe (14.93%). A total of 99 (64.28%) ADRs were observed in patients receiving four or more medications concurrently. Conversely 55 (35.71%) ADRs were detected in patients using three or less medicines. The largest number of reports was associated with antimicrobial therapy (28.57%), followed by antihypertensive (24.02%) and antidiabetics (14.28%). Among the affected organ systems, gastrointestinal ADRs constituted a major component (39.61%) followed by skin reactions (28.57%). On causality assessment, nearly 36.36% ADRs were considered as probable, 31.16% possible, and 9.74% could not be categorized and were placed under unassessable. Expected, limited ADR are permissible in normal clinical setting, but the present study focuses on the result showing increased and amplified ADR associated with the polypharmacy practices, which may be curtailed with rational drug prescribing habit. Medknow Publications 2010 /pmc/articles/PMC3035895/ /pubmed/21331200 http://dx.doi.org/10.4103/0975-1483.62222 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle General Pharmacy
Singh, H
Dulhani, N
Kumar, BN
Singh, P
Tewari, P
Nayak, K
A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India
title A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India
title_full A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India
title_fullStr A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India
title_full_unstemmed A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India
title_short A Pharmacovigilance Study in Medicine Department of Tertiary Care Hospital in Chhattisgarh (Jagdalpur), India
title_sort pharmacovigilance study in medicine department of tertiary care hospital in chhattisgarh (jagdalpur), india
topic General Pharmacy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035895/
https://www.ncbi.nlm.nih.gov/pubmed/21331200
http://dx.doi.org/10.4103/0975-1483.62222
work_keys_str_mv AT singhh apharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT dulhanin apharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT kumarbn apharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT singhp apharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT tewarip apharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT nayakk apharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT singhh pharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT dulhanin pharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT kumarbn pharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT singhp pharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT tewarip pharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia
AT nayakk pharmacovigilancestudyinmedicinedepartmentoftertiarycarehospitalinchhattisgarhjagdalpurindia